Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease.
Overwhelming data indicate that individuals with even mildly elevated blood pressure (BP) are at great risk for developing clinical hypertension and future cardiovascular disease (CVD). There remains a lack of consensus regarding treatment strategies for mildly elevated BP, termed prehypertension, and the knowledge of pathophysiology and mechanisms of its clinical outcomes remains limited. Our primary aim was to investigate βAR-mediated inflammation control (BARIC) responses of blood monocytes to isoproterenol (Iso) in relation to BP and CVD risk factors, including obesity, depressive mood, fasting glucose, triglycerides, and cholesterol levels in the 64 prehypertensive compared to 84 individuals with normal BP. BARIC was determined by measuring the degree of inhibition in lipopolysaccharides-stimulated monocytic intracellular TNF production by ex vivo Iso treatment (10(-8)M). Depressive mood was assessed by Beck Depression Inventory (BDI). Fasting metabolic and lipid panels were assessed, and plasma levels of inflammatory cytokines TNF, IL-1β, IL-6 were measured in a subset to confirm proinflammatory state of prehypertensive participants. Prehypertensive participants were older, heavier, included more men, and presented higher levels of fasting glucose, triglycerides, cholesterol, and plasma TNF compared to normotensive participants (p's<.05). BARIC was significantly attenuated in the prehypertensive compared to normotensive group (p<.05). BARIC was negatively associated with systolic BP, diastolic BP, age, BMI, fasting glucose, triglycerides, total and low density cholesterol levels, and somatic depressive symptoms in all participants (p's<.0001 to .05). However, among the prehypertensive individuals BARIC was positively associated with SBP even after controlling for the covariates (age, gender, race, BMI, glucose and lipid panel, somatic BDI scores) (p<.05). This differing nature of the BARIC-SBP relationship between the two BP groups may be attributed to moderating factors such as cardiorespiratory fitness or depressive symptoms that could not be clearly deciphered in this current study. Nonetheless, our findings indicate the associations between inflammation dysregulation mediated by sympathoadrenal activation and BP that is observable even among individuals with normal to mildly elevated BP. BARIC may be a useful and sensitive indicator of elevated risk for vascular inflammatory disease that can be detected even at lower BP levels, especially given its associations with traditional CVD risk factors and the critical role of monocytes in atherogenic processes.
['Hong|Suzi|S|', 'Dimitrov|Stoyan|S|', 'Cheng|Tiefu|T|', 'Redwine|Laura|L|', 'Pruitt|Christopher|C|', 'Mills|Paul J|PJ|', 'Ziegler|Michael G|MG|', 'Green|J Michael|JM|', 'Shaikh|Farah|F|', 'Wilson|Kathleen|K|']
D000293:Adolescent D000318:Adrenergic beta-Agonists D000328:Adult D000368:Aged D001786:Blood Glucose D001794:Blood Pressure D002318:Cardiovascular Diseases D002784:Cholesterol D003863:Depression D005260:Female D006801:Humans D007249:Inflammation D018836:Inflammation Mediators D007545:Isoproterenol D008070:Lipopolysaccharides D008297:Male D008875:Middle Aged D009000:Monocytes D011943:Receptors, Adrenergic, beta D012307:Risk Factors D014409:Tumor Necrosis Factor-alpha D055815:Young Adult
Monocytes Blood pressure Prehypertension Depression Fasting glucose Lipids Beta adrenergic receptor Intracellular TNF levels